您当前所在位置:首页 > 关于我们 > 新品上市
序号 标题 次数 作者 发布时间
86806 二乙炔基苯(PDEB)PDEB具有一个苯环和两个乙炔基团 220 WYQ 2024-11-22
86807 CAS:173308-19-5 DOTA Tris-(t-butyl ester) Ethylenediamino Monoamide 94 zyl 2024-11-22
86808 DOTA-RGD,DOTA-cRGDfK 97 kx 2024-11-22
86809 Octreotide;奥曲肽 113 wyh 2024-11-22
86810 DOTA-NHS-酯 六氟磷酸盐 TFA 盐 DOTA-NHS-ester Hexafluorophosphate TFA Salt 101 zyl 2024-11-22
86811 DOTA-NHS-酯 六氟磷酸盐 TFA 盐 DOTA-NHS-ester Hexafluorophosphate TFA Salt 154 zyl 2024-11-22
86812 Ga-DOTA-TOC acetate ;293295-70-2 99 wyh 2024-11-22
86813 聚(间二乙炔基苯-苯基氢硅烷)(PDBS) 150 WYQ 2024-11-22
86814 端乙炔基材料4,4′-双(3-乙炔基苯氧基)二苯基砜(ATS) 82 WYQ 2024-11-22
86815 DOTA-mono-NHS tris (t-Bu ester) Hydrogen Hexafluorophosphate 97 wyh 2024-11-22
86816 CAS:127985-74-4 p-SCN-Bn-DOTA 101 zyl 2024-11-22
86817 聚甲基硅次乙炔基硅烷(MSE) 128 WYQ 2024-11-22
86818 聚苯基二乙炔基苯硅烷(MSP) 169 WYQ 2024-11-22
86819 N,N-二炔丙基-3-乙炔基苯胺(DPEA) 130 WYQ 2024-11-22
86820 乙炔基封端的氢化超支化聚碳硅烷(EHBP) 93 WYQ 2024-11-22
86821 CAS:819869-77-7 DOTA-tris(tBu)ester NHS ester 87 zyl 2024-11-22
86822 CAS:180978-54-5 DOTA-Biotin-Sarcosine DOTA-生物素-肌氨酸 92 zyl 2024-11-22
86823 端乙炔基聚醚酰亚胺改性硅芳炔树脂(PEI-PSA) 109 WYQ 2024-11-22
86824 DOTA 偶联肽,NOTA-E(cRGDfK)2,NOTA标记多肽氨基酸试剂 142 kx 2024-11-22
86825 Lutetium (177Lu) oxodotreotide;437608-50-9 108 wyh 2024-11-22
86826 CAS:2125661-62-1 Butyne-DOTA 97 zyl 2024-11-22
86827 端乙炔基聚醚酰亚胺(PEI)(Polyetherimide,简称PEI) 222 WYQ 2024-11-22
86828 碳/聚硅乙炔基防热复合材料(C/PMR) 134 WYQ 2024-11-22
86829 聚(间二乙炔基苯-甲基氢硅烷)树脂(PSA) 269 WYQ 2024-11-22
86830 P-氨基苯乙炔基共轭侧基的聚对苯撑乙炔(PAnPE) 116 WYQ 2024-11-22
86831 DOTA-G5 DOTA修饰修饰第5代(G5)聚(酰胺基胺)树枝状聚合物 125 zcy 2024-11-22
86832 DOTA-PEG5-azide 大环化合物-五聚乙二醇-叠氮 93 zyl 2024-11-22
86833 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, a-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl) ester 113 wyh 2024-11-22
86834 DOTA功能化的聚赖氨酸 130 zcy 2024-11-22
86835 聚乳酸-羟基乙酸共聚物-大环配体 129 wyh 2024-11-22
86836 DOTA-Tyr3-thre8-奥曲肽 DOTA-Tyr3-Thre8-octreotide 104 zcy 2024-11-22
86837 1,4,7,10-Tetrakis(aminocarbonylmethyl)-1,4,7,10-tetraazacyclododecane 93 wyh 2024-11-22
86838 BKT140CXCR4 antagonist-DOTA 105 zyl 2024-11-22
86839 CAS:181065-46-3 p-NH2-Bn-DOTA(B-200) 110 zyl 2024-11-22
86840 DOTA di(tBu)ester;913542-71-9 119 wyh 2024-11-22
86841 10,10'-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸],三氟乙酸盐;1175002-77-3 97 wyh 2024-11-22
86842 (R)-tert-Bu4-DOTAGA;817562-90-6 111 wyh 2024-11-22
86843 DOTA-Bevacizumab DOTA-贝伐单抗 114 zcy 2024-11-22
86844 10-[2-[(3,5-二羧基苯基)氨基]-2-氧乙基]-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸,三氟乙酸盐 103 wyh 2024-11-22
86845 DOTA接枝N-乙烯基吡咯烷酮-丙烯醛P(VP-Ac)共聚物 DOTA-VP-Ac 116 zcy 2024-11-22
86846 DOTA-HYNIC-IPSMA 111 wyh 2024-11-22
86847 PEG-GO 聚乙二醇化超小GO氧化石墨烯的二维纳米材料 266 zcy 2024-11-22
86848 CAS1227407-76-2 叠氮基-单-酰胺-DOTA Azido-mono-amide-DOTA 94 zyl 2024-11-22
86849 (S)-N-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYL)-6-(METHYL(3-(PIPERAZIN-1-YL)PROPYL)AMINO)QUINOLINE-4-CARBOXAMIDE 115 wyh 2024-11-22
86850 DOTA(Tris)-EA-TEG-NH2-CBZ DOTA(Tris)-乙胺(EA)偶联四甘醇(TEG) 207 zcy 2024-11-22
库存查询